Recent FDA enforcement actions against illegal, tainted products masquerading as dietary supplements since February 21, 2014 (FDA

AHPA Alerts

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe

View recent alerts:

  • Legal Alerts News on dietary supplement laws, regulations and enforcement
  • Science Alerts The latest research on herbs and botanicals
  • Market Alerts Herbal market trends and AHPA-member press releases
  • Media Alerts Media coverage of the herbal industry 
  • Cannabis Alerts The latest research and news about hemp, CBD and medical marijuana
  • Cosmetic Alerts Regulatory updates and personal care product news

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

Recent FDA enforcement actions against illegal, tainted products masquerading as dietary supplements since February 21, 2014 (FDA

Published: Friday, March 28, 2014

Since February 21, 2014, the Food and Drug Administration (FDA) has performed four enforcement actions advising consumers not to purchase or use products because FDA laboratory analysis confirmed that these products contain undeclared ingredients.

FDA issued two voluntary recalls for four weight loss products, and two public notifications on one  sexual enhancement product and one weight loss product that "contain hidden drug ingredients." 
The Australian health agency issued 11 safety advisories in the last month. The agency issued five advisories for sexual enhancement products and six for weight loss products that "contain hidden drug ingredients."
AHPA maintains a website (KeepSupplementsClean.org) that tracks the latest FDA enforcement actions taken against illegal, tainted products being sold as "dietary supplements." The site provides detailed resources and information for the supplement industry and consumers.
Browse the latest enforcement actions taken by FDA and international health agencies using the links below.

 

 

 

 

Print

2022 Annual Fund Sponsors

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.